JP2024526191A5 - - Google Patents
Info
- Publication number
- JP2024526191A5 JP2024526191A5 JP2023579304A JP2023579304A JP2024526191A5 JP 2024526191 A5 JP2024526191 A5 JP 2024526191A5 JP 2023579304 A JP2023579304 A JP 2023579304A JP 2023579304 A JP2023579304 A JP 2023579304A JP 2024526191 A5 JP2024526191 A5 JP 2024526191A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- isotopolog
- tautomer
- stereoisomer
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163215243P | 2021-06-25 | 2021-06-25 | |
| US63/215,243 | 2021-06-25 | ||
| PCT/US2022/034921 WO2022272074A1 (en) | 2021-06-25 | 2022-06-24 | Cereblon binding compounds, compositions thereof, and methods of treatment therewith |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024526191A JP2024526191A (ja) | 2024-07-17 |
| JP2024526191A5 true JP2024526191A5 (https=) | 2025-06-30 |
Family
ID=84543920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023579304A Pending JP2024526191A (ja) | 2021-06-25 | 2022-06-24 | セレブロン結合化合物、その組成物及びそれによる治療方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240368118A1 (https=) |
| EP (1) | EP4359407A4 (https=) |
| JP (1) | JP2024526191A (https=) |
| KR (1) | KR20240026939A (https=) |
| CN (1) | CN117561249A (https=) |
| WO (1) | WO2022272074A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4692061A1 (en) * | 2023-03-29 | 2026-02-11 | Aevis Bio, Inc. | Low-molecular-weight compound having cereblon-binding activity, and use thereof |
| AU2024298923A1 (en) | 2023-07-25 | 2026-01-22 | Monte Rosa Therapeutics Ag | Substituted piperidinediones for targeted protein degradation |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6817962B2 (ja) * | 2015-01-20 | 2021-01-20 | アルビナス・オペレーションズ・インコーポレイテッドＡｒｖｉｎａｓ Ｏｐｅｒａｔｉｏｎｓ， Ｉｎｃ． | ターゲティングされたアンドロゲン受容体分解のための化合物および方法 |
| TWI726969B (zh) * | 2016-01-11 | 2021-05-11 | 比利時商健生藥品公司 | 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物 |
| IL312367A (en) * | 2017-01-31 | 2024-06-01 | Arvinas Operations Inc | Cereblon ligands and bifunctional compounds comprising the same |
| EP3658548A1 (en) * | 2017-07-28 | 2020-06-03 | Arvinas Operations, Inc. | Compounds and methods for the targeted degradation of androgen receptor |
| CN113453681B (zh) * | 2018-12-19 | 2024-10-11 | 细胞基因公司 | 经取代的3-((3-氨基苯基)氨基)哌啶-2，6-二酮化合物、其组合物及使用它们的治疗方法 |
| CN114521196A (zh) * | 2019-09-16 | 2022-05-20 | 诺华股份有限公司 | 双官能团降解剂及其使用方法 |
| KR20230027066A (ko) * | 2020-06-24 | 2023-02-27 | 셀진 코포레이션 | 세레블론 결합 화합물, 이의 조성물, 및 이에 의한 치료 방법 |
-
2022
- 2022-06-24 CN CN202280044021.6A patent/CN117561249A/zh active Pending
- 2022-06-24 JP JP2023579304A patent/JP2024526191A/ja active Pending
- 2022-06-24 WO PCT/US2022/034921 patent/WO2022272074A1/en not_active Ceased
- 2022-06-24 KR KR1020237044476A patent/KR20240026939A/ko active Pending
- 2022-06-24 EP EP22829394.0A patent/EP4359407A4/en active Pending
- 2022-06-24 US US18/573,723 patent/US20240368118A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023533203A5 (https=) | ||
| JP2023531709A5 (https=) | ||
| JP2023531495A5 (https=) | ||
| JP2022512482A5 (https=) | ||
| JP2022520448A5 (https=) | ||
| JP2024520481A5 (https=) | ||
| WO2021203768A1 (zh) | 嘧啶并二环类衍生物、其制备方法及其在医药上的应用 | |
| CN113365997A (zh) | 作为c-Met抑制剂的含嘧啶基团的三并环类化合物 | |
| JP7759877B2 (ja) | 治療用化合物 | |
| JP2022541467A (ja) | オーロラキナーゼ阻害剤およびその使用 | |
| JP2024526191A5 (https=) | ||
| JP2021535207A5 (https=) | ||
| WO2019134539A1 (zh) | 二氢吡唑酮并嘧啶类化合物及其制备方法和用途 | |
| JP2008509949A5 (https=) | ||
| JP2011509309A5 (https=) | ||
| JP2020063289A5 (https=) | ||
| JP2024516033A5 (https=) | ||
| JP2022534704A5 (https=) | ||
| JP2014514290A5 (https=) | ||
| JP7112755B2 (ja) | Ｊａｋ酵素阻害剤及びその製造方法と用途 | |
| JP2008513485A5 (https=) | ||
| JP2014520108A5 (https=) | ||
| CN115677664A (zh) | 作为parp7抑制剂的哒嗪酮类化合物 | |
| AU2005335298A1 (en) | N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof | |
| JP2007531766A5 (https=) |